MORE SHOTS: Vax Maker Pushes Another Round of Shots for Omicron Variant

Will it ever end?  Will our world ever go back to normal?  Is there any chance that we’ll live in a world, any time soon, in which vaccines and masks and social distancing are a thing of the past?

It certainly doesn’t seem plausible at the moment, especially when we have vaccine manufacturers using the latest, mild, omicron variant of COVID-19 to push more shots on the masses.

Preliminary lab studies show two doses of the Pfizer/BioNTech vaccine may not provide sufficient protection against the Omicron coronavirus variant, but three doses are able to neutralize it, the companies said in a news release on Wednesday.

Samples from people who had two doses of the Covid-19 vaccine saw, on average, a more than 25-fold reduction in neutralization ability against the Omicron variant than the earlier virus, “indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant,” the companies said.

The companies said two doses may still provide protection against severe disease.
“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” Pfizer Chairman and CEO Albert Bourla said in a statement. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”

Health officials who’ve been treating omicron patients in South Africa, where the variant was first detected, have considered the symptoms to be “mild”, with the average hospital stay of those affected clocking in a less than half of that of other variants.